Streetbeat News

MCAG

Mountain Crest Acquisition Corp. V

https://www.mcacquisition.com/Mountain-Crest-V-/default.aspx

Industry

Shell Companies

Mountain Crest Acquisition Corp. V does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Mountain Crest Acquisition Corp. V has received a deficiency notification from Nasdaq due to non-compliance with listing rules. The company has 180 days to regain compliance.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2024 | 8:31 pm

Mountain Crest Acquisition Corp. V has received a notification of deficiency from Nasdaq, indicating that the company is not in compliance with certain listing requirements.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 9:01 pm

Mountain Crest Acquisition Corp. V (NASDAQ:MCAG), a SPAC, and CUBEBIO, a Korean company with cancer diagnostic technology, announced a non-binding term sheet for a business combination, aiming to take CUBEBIO public on Nasdaq. The pre-transaction equity value of CUBEBIO is set at $620 million, with adjustments pending further due diligence and market conditions. Global Fund LLC is advising CUBEBIO on the transaction. Both companies' leadership expressed optimism about the growth potential and global expansion following the merger.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 1:14 pm

Trading for MCAG was halted at 8:55:00 a.m. ET due to pending news. The halt is a temporary measure until the news affecting the company is released.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 12:55 pm

AUM Biosciences has dosed its first patient in a Phase 2 clinical trial for AUM001, a treatment for metastatic colorectal cancer. The trial is being conducted in collaboration with MSD, a tradename of Merck & Co., Inc. AUM Biosciences plans to merge with Mountain Crest Acquisition Corp. V (NASDAQ:MCAG) and trade on the Nasdaq under the ticker symbol AUMB.

Portfolio Pulse from Happy Mohamed

May 30, 2023 | 12:09 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.